Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 12:30 AM
Ignite Modification Date:
2025-12-25 @ 12:30 AM
NCT ID:
NCT07116967
Brief Summary:
A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis
Study:
NCT07116967
Study Brief:
Protocol Section:
NCT07116967